The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Siddhant Kabra
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The stock exchange has received a disclosure under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, filed by Siddhant Kabra in relation to Eiko Lifesciences Ltd. This type of filing is required when an insider or shareholder reports a change in their voting rights in the company. The headline does not specify whether the change was an increase or decrease, nor the exact percentage moved.
Limited information is available from this headline alone, so the direct impact on shareholders is unclear. Investors should look for the detailed disclosure to know whether the insider is buying or selling and assess the change in holding accordingly.